Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00913757 · ClinicalTrials.gov registry record
A Study of Molecular and Genetic Factors for Liver Cancer in the Greater Baltimore Area
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 1,871
- Enrollment target
NCT00913757: Completed study, sponsored by National Cancer Institute (NCI).
NCT00913757 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 1,871 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00913757 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 1,871 participants
- Enrollment target
Study Summary
Background: * Liver cancer is the third most deadly and fifth most common cancer worldwide. Hepatocellular carcinoma (HCC) is the most frequent primary liver cancer, and it has grown more prevalent in the United States. * More information is needed about the causes and effects of liver cancer, and further research into individuals who are at high risk for developing liver cancer is needed for early diagnosis and prevention. Objectives: * To identify genetic factors that may help to explain the aggressiveness of liver cancer. * To determine if HCC biomarkers exist in blood, urine, and tissue samples. Eligibility: * Patients between the ages of 18 and 90 who have been diagnosed with HCC or have a high risk for developing HCC because of fatty liver disease (alcohol-related or non-alcohol-related) or chronic hepatitis B or C. * Participants will reside in Baltimore City and the surrounding areas. Design: * Participants will complete a questionnaire and provide blood and urine samples for testing: * The questionnaire will include questions about individual and family medical history, tobacco use, and exposure to known factors for liver cancer. * Blood and urine samples will be collected from all participants after the questionnaire. * Tumor tissue and healthy tissue will be collected from selected participants if they undergo surgery for their cancer or disease. * No specific treatment will be offered as part of this protocol, but participants have the option to be treated under different protocols.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,871 participants |
| Start Date | 2009-07-01 |
| Est. Completion | 2020-05-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00913757
The ClinicalTrials.gov registry entry for NCT00913757 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,871 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00913757 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00913757 about?
NCT00913757 is a clinical study titled "A Study of Molecular and Genetic Factors for Liver Cancer in the Greater Baltimore Area". Background: * Liver cancer is the third most deadly and fifth most common cancer worldwide. Hepatocellular carcinoma (HCC) is the most frequent primary liver cancer, and it has grown more prevalent in the United States. * More information is needed about the causes and effects of liver cancer, and ...
What is the current status of trial NCT00913757?
This trial is currently completed. The enrollment target is 1,871 participants. The study started on 2009-07-01. Estimated completion is 2020-05-01.
Who is sponsoring clinical trial NCT00913757?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.